Laura N Eadie

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

South Australian Health and Medical Research Institute

University of Adelaide (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

South Australian Health and Medical Research Institute

Australia

Post Doctoral Research Fellow :: Precision Medicine Theme

St. Jude Children's Research Hospital Aug 15 2016 - Aug 14 2017

United States

Post Doctoral Research Associate :: Pathology

SA Pathology

Australia

Post Doctoral Researcher

SA Pathology

Australia

Research Assistant

South Australian Research and Development Institute

Australia

Laboratory Technician

Education History

University of Adelaide

Australia

PHD

University of Adelaide

Australia

BSC

University of Adelaide

Australia

BSC

Publications

Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle O Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood 144 (9) (2024)
Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle O Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood 144 (9) (2024)
Laura N Eadie, Elias Lagonik, Elyse C Page, Caitlin E Schutz, Susan L Heatley, Barbara J McClure, Michelle Olivia Forgione, David T O Yeung, Timothy P Hughes, Deborah L White
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood (2024)
Laura N Eadie, Jacqueline A Rehn, Caitlin E Schutz, Susan L Heatley, Monika M Kutyna, Devendra K Hiwase, Deborah L White, David T O Yeung
Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling. British journal of haematology (2023)
Laura N Eadie, Jacqueline A Rehn, James Breen, Michael Philip Osborn, Sophie Jessop, Charlotte E J Downes, Susan L Heatley, Barbara J McClure, David T Yeung, Tamas Revesz, Benjamin Saxon, Deborah L White
Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A -Rearranged Acute Lymphoblastic Leukemia. Genes 14 (2) (2023)
Laura N Eadie, Jacqueline A Rehn, James Breen, Michael Philip Osborn, Sophie Jessop, Charlotte E J Downes, Susan L Heatley, Barbara J McClure, David T Yeung, Tamas Revesz, Benjamin Saxon, Deborah L White
Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A -Rearranged Acute Lymphoblastic Leukemia. Genes 14 (2) (2023)
Laura N Eadie, Jacqueline A Rehn, James Breen, Michael Philip Osborn, Sophie Jessop, Charlotte E J Downes, Susan L Heatley, Barbara J McClure, David T Yeung, Tamas Revesz, Benjamin Saxon, Deborah L White
Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A -Rearranged Acute Lymphoblastic Leukemia. Genes 14 (2) (2023)
Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley, Laura N Eadie, Elyse C Page, Caitlin Schutz, Barbara J McClure, Rosemary Sutton, Luciano Dalla-Pozza, Andrew S Moore, Matthew Greenwood, Rishi Sury Kotecha, Chun Yew Fong, Agnes S M Yong, David T Yeung, James Breen, Deborah L White
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients. Cancers 15 (19) (2023)
Laura N Eadie, Jacqueline A Rehn, James Breen, Michael Philip Osborn, Sophie Jessop, Charlotte E J Downes, Susan L Heatley, Barbara J McClure, David T Yeung, Tamas Revesz, Benjamin Saxon, Deborah L White
Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A -Rearranged Acute Lymphoblastic Leukemia. Genes 14 (2) (2023)
Jacqueline Rehn, Chelsea Mayoh, Susan L Heatley, Barbara J McClure, Laura N Eadie, Caitlin Schutz, David T Yeung, Mark J Cowley, James Breen, Deborah L White
RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL). PLoS genetics 18 (10) (2022)
Susan L Heatley, Kartini Asari, Caitlin E Schutz, Tamara M Leclercq, Barbara J McClure, Laura N Eadie, Timothy P Hughes, David T Yeung, Deborah L White
In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy. Leukemia & lymphoma 62 (5) (2021)
Michelle Olivia Forgione, Barbara J McClure, David T O Yeung, Laura N Eadie, Deborah L White
MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies. Genes, chromosomes & cancer (2020)
Laura N Eadie, Phuong Dang, Jarrad M Goyne, Timothy P Hughes, Deborah L White
ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells. PloS one 13 (1) (2018)
Laura N Eadie, Timothy P Hughes, Deborah L White
ABCB1 Overexpression Is a Key Initiator of Resistance to Tyrosine Kinase Inhibitors in CML Cell Lines. PloS one 11 (8) (2016)

Laura N Eadie

Publication Activity (10 Years)

Top Topics

Top Venues